Microbio Statistics

Total Valuation

Microbio has a market cap or net worth of TWD 16.29 billion. The enterprise value is 15.76 billion.

Market Cap	16.29B
Enterprise Value	15.76B

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Microbio has 588.17 million shares outstanding.

Current Share Class	588.17M
Shares Outstanding	588.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	6.39%
Float	428.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.22
PB Ratio	1.45
P/TBV Ratio	1.71
P/FCF Ratio	23.49
P/OCF Ratio	22.46
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.20
EV / Sales	8.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	22.73

Financial Position

The company has a current ratio of 6.50, with a Debt / Equity ratio of 0.05.

Current Ratio	6.50
Quick Ratio	5.91
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	0.82
Interest Coverage	-42.63

Financial Efficiency

Return on equity (ROE) is -10.50% and return on invested capital (ROIC) is -2.16%.

Return on Equity (ROE)	-10.50%
Return on Assets (ROA)	-2.01%
Return on Invested Capital (ROIC)	-2.16%
Return on Capital Employed (ROCE)	-3.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.13
Inventory Turnover	5.15

Taxes

In the past 12 months, Microbio has paid 171,000 in taxes.

Income Tax	171,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.73% in the last 52 weeks. The beta is 0.58, so Microbio's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-27.73%
50-Day Moving Average	23.67
200-Day Moving Average	33.01
Relative Strength Index (RSI)	72.89
Average Volume (20 Days)	877,168

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbio had revenue of TWD 1.77 billion and -1.11 billion in losses. Loss per share was -1.89.

Revenue	1.77B
Gross Profit	692.61M
Operating Income	-442.49M
Pretax Income	-1.28B
Net Income	-1.11B
EBITDA	-341.54M
EBIT	-442.49M
Loss Per Share	-1.89

Full Income Statement

Balance Sheet

The company has 2.67 billion in cash and 569.55 million in debt, giving a net cash position of 2.10 billion or 3.57 per share.

Cash & Cash Equivalents	2.67B
Total Debt	569.55M
Net Cash	2.10B
Net Cash Per Share	3.57
Equity (Book Value)	11.26B
Book Value Per Share	16.48
Working Capital	2.57B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 725.51 million and capital expenditures -31.99 million, giving a free cash flow of 693.53 million.

Operating Cash Flow	725.51M
Capital Expenditures	-31.99M
Free Cash Flow	693.53M
FCF Per Share	1.18

Full Cash Flow Statement

Margins

Gross margin is 39.20%, with operating and profit margins of -25.04% and -62.84%.

Gross Margin	39.20%
Operating Margin	-25.04%
Pretax Margin	-72.57%
Profit Margin	-62.84%
EBITDA Margin	-19.33%
EBIT Margin	-25.04%
FCF Margin	39.25%

Dividends & Yields

Microbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.81%
FCF Yield	4.26%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	1.049999998

Scores

Microbio has an Altman Z-Score of 6.82 and a Piotroski F-Score of 4.

Altman Z-Score	6.82
Piotroski F-Score	4